Results

1–10 of 13 results for PREVENT

Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy
Hani Salehi-Had, MD, FASRS
Annual Meeting Talks
2023
Phase 3 GUARD Trial of ADX-2191 (Methotrexate for Intravitreal Administration) to Prevent Proliferative Vitreoretinopathy and Other Postoperative Complications
Christina Joy Flaxel, MD
Annual Meeting Talks
2023
Key Surgical Pearls for the Prevention of Conjunctival Complications Following the Port Delivery System With Ranibizumab (PDS) Implant Insertion Procedure
On Demand Cases, Courses, and Papers
2022
Anti-VEGF Therapy to Prevent Macular Fibrosis in Coats Disease
On Demand Cases, Courses, and Papers
2022
Can We Prevent Posterior Synechia Formation Using a Topical Short-Acting Mydriatic in Combined Phacoemulsificationâ€“Pars Plana Vitrectomy Surgery? Prospective Study
On Demand Cases, Courses, and Papers
2022
Oral Methotrexate as a Method of Preventing Proliferative Vitreoretinopathy
On Demand Cases, Courses, and Papers
2022
A Randomized Trial of Intravitreous Anti-VEGF for Prevention of Vision Threatening Complications of Diabetic Retinopathy (Protocol W)
Raj K. Maturi, MD
Annual Meeting Talks
2021
VEGF Blockage Prevents Healthy Retinal Regeneration - Norrin Protein Promotes VEGF Modulation and Healthy In-Situ Retinal Regeneration in Vascular Disease
Michael T. Trese, MD
Annual Meeting Talks
2020
Preventing oil overfill: The reservoir technique for silicone oil surgery
Michael M. Altaweel, MD
On Demand Cases, Courses, and Papers
2019
A Randomized Trial of Intravitreous Anti-VEGF for Prevention of Vision Threatening Complications of Diabetic Retinopathy (Protocol W)
Raj K. Maturi, MD
Updates from the Field
2021